ERYTECH Pharma announces the oral presentation of positive Phase II clinical trial results in Acute Lymphoblastic Leukemia. admERY June 17, 2012 Newsroom You Might Also Like ERYTECH business update and financial results for the first half of 2014 September 2, 2014 ERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018 April 12, 2018 ERYTECH provides business update and financial results for the first half of 2015 September 28, 2015
ERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018 April 12, 2018
